ATHNA BIOTECH

Athna Biotech specializes in developing novel nanotherapeutics for cancer. The SCNPs developed by Athna Biotech accurately target cancer cells, causing them to disintegrate and release tumor antigens as well as damage-associated molecular pattern molecules. These molecules help recruit dendritic cells, which leads to antigen-specific immunity. Because SCNPs are derived from a benign electrolyte, the side effects are minimal. Athnaโ€™s development addresses a gap in the market that BCG seems unable to fill. The global urothelial cancer drug market was valued at $855 million in 2017; it is expected to reach $3.6 billion by 2023. Athna is on track to compete for the NCI Experimental Therapeutics (NExT) program, bringing its drug closer to clinical use.

#SimilarOrganizations #More

ATHNA BIOTECH

Industry:
Biotechnology Health Care Medical

Status:
Active


Similar Organizations

abound-bio-logo

Abound Bio

Abound Bio specializes in generating antibody-based biological therapeutics to meet medical needs in the fields of cancer.

apiquiet-sprl-logo

Apiquiet SPRL

Apiquiet SPRL specializes in the development of solutions and services that allow the elderly to live longer at home.

not_available_image

Arestyr OncoLogic

Arestyr OncoLogic is a biotechnology company that develops both diagnostics and therapies for cancer.

enzyme-by-design-logo

ENZYME BY DESIGN

ENZYME BY DESIGN specializes in safe cancer therapeutics services.

not_available_image

Kreatech Biotechnology

Kreatech Biotechnology is a agency that specializes in pathology solutions for medical businesses.

not_available_image

Menssana Research

Menssana Research is the leading developer of advanced new breath tests for detection of disease.

not_available_image

NasasBiotech

Biomedicine start-up developing and commercializing metastatic tumor cells capturing devices.

project-mine-logo

Project Mine

Project Mine specializes in the genetic research and consulting services of human DNA.

sugen-logo

Sugen

Sugen specializes in target-driven drug discovery and development for novel development-stage cancer therapies.

tavec-pharma-logo

Tavec pharma

Tavec Pharmaceuticals is developing injectable therapies to treat cancers.

More informations about "Athna Biotech"

Athna Biotech, Inc.

The company is located in a rapidly expanding biotechnology industrial and academic region, giving it a unique position at the forefront of advanced technology and biomaterial โ€ฆSee details»

Athna Biotech - Crunchbase Company Profile & Funding

Athna Biotech specializes in developing novel nanotherapeutics for cancer. The SCNPs developed by Athna Biotech accurately target cancer cells, causing them to disintegrate and โ€ฆSee details»

Policies - Athna Biotech, Inc.

The PI of each research project and the financial manager or administrator of Athna Biotech, Inc. will ensure and the subcontract organizations following the funding agencyโ€™s policy on โ€ฆSee details»

Athna Biotech, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Athna Biotech, Inc. of Watkinsville, GA. Get the latest business insights from Dun & Bradstreet.See details»

Athna Biotech - Tech Stack, Apps, Patents & Trademarks

Athna Biotech specializes in developing novel nanotherapeutics for cancer.See details»

ATHNA BIOTECH INC - VentureRadar

Athna Biotech is a cutting-edge startup that was established by a team of biomedical researchers, engineers, and clinical scientists who specialize in life sciences, diagnostics, and the โ€ฆSee details»

ATHNA BIOTECH INC | SBIR.gov

ABSTRACT Nonโ€“small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality. NSCLC accounts for 85% of all lung cancers, and is diagnosed in 234,030 persons each year โ€ฆSee details»

Firm - SBIR

Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https:// means โ€ฆSee details»

Georgia Research Alliance - GRA

Athna Biotech Industry: Pharmaceutical cancer treatment. Athna Biotech specializes in developing novel nanotherapeutics for cancer. Their research in sodium chloride nanoparticles (SCNPs) โ€ฆSee details»

Zhi Liu - Chief Scientist - ATHNA BIOTECH INC - LinkedIn

Chief Scientist @ ATHNA BIOTECH INC · Experience: ATHNA BIOTECH INC · Education: University of Chinese Academy of Sciences · Location: Athens · 276 connections on LinkedIn. โ€ฆSee details»

RePORT โŒช RePORTER

Awardee Organization ATHNA BIOTECH, INC. Description. Abstract Text. ABSTRACT Nonโ€“small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality. NSCLC โ€ฆSee details»

Athna Biotech, Inc. - VentureRadar

Athna Biotech, Inc. is developing a new chemoradiotherapy (CRT) approach, for the treatment of Nonโ€“small cell lung cancer (NSCLC), where radiation is utilized to locally activate systemically โ€ฆSee details»

Athna Biotech (LBCCTS71U2N4) - HigherGov

Federal grant recipient ATHNA BIOTECH INC (UEI LBCCTS71U2N4, CAGE 8CKB5) is headquartered in Watkinsville GA. Its primary registered NAICS is 541713 Research and โ€ฆSee details»

Award - SBIR

Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https:// means โ€ฆSee details»

TEAM - Athna Biotech, Inc.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.See details»

News - Athna Biotech, Inc.

Jun 14, 2021 Athna Biotech, Inc. received a Phase I Small Business Innovation Research (SBIR) grant from NIH NCI to develop a salt-based nanomedicine for non-muscle invasive โ€ฆSee details»

Development of a radiation-activatable nanoparticle for lung โ€ฆ

For Support Organizations; For Federal Agencies; You are here. Home » Award Details. Development of a radiation-activatable nanoparticle for lung cancer therapy. ... ATHNA โ€ฆSee details»

RePORT โŒช RePORTER

Awardee Organization ATHNA BIOTECH, INC. Description. Abstract Text. Abstract Bladder cancer comprises 7% of new cancer diagnoses in the US. It is the sixth most prevalent โ€ฆSee details»

Establishing Canadaโ€™s first large-scale bioinnovation centre

Mar 20, 2025 A one-of-a-kind facility in Canada, the Neptune BioInnovation Centre (NBC) will encourage biotechnology advancements in areas such as smart materials, bioplastics, โ€ฆSee details»

Career - Athna Biotech, Inc.

At Athna Biotech, we are committed to maintaining the growth and success of our business by bringing in the best and brightest talent. We have a high-caliber team of innovative individuals, โ€ฆSee details»

linkstock.net © 2022. All rights reserved